Lactose (India) Limited has submitted its quarterly compliance certificate to BSE Limited under SEBI regulations for the fourth quarter ended March 31, 2026. The filing demonstrates the company's adherence to mandatory regulatory requirements for securities dematerialization.

Regulatory Compliance Certificate

The certificate was filed under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that all details of securities dematerialized during Q4 FY26 have been properly furnished to BSE Limited. Company Secretary Ritesh Pandey signed and submitted the certificate on April 13, 2026.

Registrar Confirmation

Bigshare Services Private Limited, serving as the company's registrar and share transfer agent, provided confirmation dated April 13, 2026, supporting the compliance certificate. The registrar confirmed that:

• Securities received from depository participants for dematerialization up to March 31, 2026 were properly confirmed to the depositories
• All securities comprised in the certificates have been listed on the stock exchange where earlier issued securities are listed
• Security certificates received for dematerialization have been mutilated and cancelled after due verification
• Names of depositories have been substituted in the register of members as registered owners within 15 days of receipt

Akash Shamal signed the confirmation letter as authorized signatory for Bigshare Services Private Limited.

Corporate Information

Lactose (India) Limited operates from its registered office at Survey No. 5, 6 & 7A, Village Poicha (Rania), Taluka Savli, District Vadodara, Gujarat. The company maintains its corporate office at Navbharat Estate, Sewri (W), Mumbai, and holds ISO 9001 certification from TUV NORD.

This quarterly filing represents standard regulatory compliance for listed companies, ensuring transparency in securities dematerialization processes and maintaining investor confidence through proper documentation and verification procedures.

Lactose (India) Limited successfully conducted its Extra Ordinary General Meeting (EOGM) on March 28, 2026, securing overwhelming shareholder approval for the scheme of amalgamation with Vitanosh Ingredients Private Limited (VIPL). The meeting, held through video conferencing from 10:30 AM to 10:51 AM, achieved remarkable voting results with 99.99% votes in favor of the merger resolution.

EGM Proceedings and Participation

The meeting was conducted in accordance with circulars issued by the Ministry of Corporate Affairs and SEBI, with comprehensive e-voting facilities provided to shareholders. Remote e-voting was available from March 25, 2026, at 09:00 AM to March 27, 2026, at 05:00 PM, with additional e-voting facility remaining active throughout the EGM proceedings.

Voting Results and Shareholder Response

The special resolution for the merger scheme received exceptional support from shareholders across all categories. Out of 12,589,000 total shares, 5,919,674 votes were polled, representing 47.02% participation. The voting breakdown demonstrates strong confidence in the merger strategy.

Official Scrutinizer Report and Regulatory Compliance

Arjun Lakhanpal, appointed as scrutinizer by the National Company Law Tribunal, Ahmedabad Bench, submitted comprehensive reports confirming the voting results. The scrutinizer report details that Bigshare Services Private Limited served as the e-voting agency, with votes unblocked on March 28, 2026 at 11:17 AM in the presence of witnesses Mr. Vishal Kotecha and Mr. Raimeen Maradiya.

Merger Impact and Shareholding Changes

The approved merger will result in significant changes to the company's shareholding structure, with promoter shareholding increasing from 53.65% to 58.84%. Under the merger terms, VIPL shareholders will receive 0.7946 equity shares of Lactose (India) Limited for every 1 fully paid-up equity share of VIPL.

Financial Performance and Strategic Benefits

The merger combines two entities with contrasting financial profiles. Lactose (India) Limited demonstrates strong operational performance with revenue of ₹11,639.93 lakhs and profit after tax of ₹516.29 lakhs for March 2025, while VIPL reported revenue of ₹34.69 lakhs but incurred losses of ₹195.57 lakhs during the same period. The merger will expand production capacity from 10,000 MT per annum to 15,000 MT per annum, providing immediate capacity enhancement and an expanded product portfolio including high-margin Inhalation Grade Lactose.

Next Steps and Regulatory Approval

The voting results have been disclosed to BSE Limited under Regulation 30 and 44(3) of the Listing Regulations. Company Secretary Ritesh Pandey has reported the successful EGM results to the Hon'ble National Company Law Tribunal, Ahmedabad Bench, representing a crucial milestone toward final regulatory approval of the amalgamation scheme. The comprehensive documentation and overwhelming shareholder support position the merger for smooth regulatory clearance.